A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer.
Kamaraju S, Fowler AM, Tarima S, Chaudhary LN, Burkard ME, Giever T, Cheng YC, Parkes A, Lange CA, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns JM, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K.
Kamaraju S, et al. Among authors: lange ca.
Clin Breast Cancer. 2024 Dec 10:S1526-8209(24)00333-1. doi: 10.1016/j.clbc.2024.11.019. Online ahead of print.
Clin Breast Cancer. 2024.
PMID: 39824712